U.S. market Closed. Opens in 1 day 5 hours 21 minutes

CRNX | Crinetics Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue4.01M4.74M1.08M71.00K1.19M2.43M2.04M589.00K
Cost of RevenueN/A1.39M1.26M57.00M1.11M24.48M9.23M5.10M
Gross Profit4.01M3.35M-184.00K-56.93M80.00K-22.05M-7.19M-4.51M
Operating Expenses226.62M172.62M108.78M74.95M53.83M28.71M9.13M6.04M
Selling, General & Admin58.09M42.39M24.52M18.03M13.52M6.66M1.94M1.53M
Research & Development168.53M130.22M84.25M57.00M41.51M24.48M9.23M5.10M
Other Operating ExpensesN/A4.97M61.00K-71.00K-1.19M1.59M-48.00K-1.00K
Operating Income-222.61M-167.88M-107.70M-74.95M-53.83M-28.71M-9.13M-6.04M
Other Expenses / Income8.08M3.96M61.00K1.14M3.41M1.59M-30.00K25.00K
Before Tax Income-214.53M-163.92M-107.64M-73.81M-50.42M-27.11M-9.16M-6.02M
Income Tax ExpensesN/A-3.96M-922.00K-948.00K-887.00K1.59M-40.00K10.00K
Net Income-214.53M-159.95M-106.72M-72.86M-49.53M-27.11M-9.16M-6.02M
Interest ExpensesN/A4.32MN/AN/AN/AN/A8.00K11.00K
Basic Shares Outstanding58.07M51.98M38.44M30.45M24.18M12.14M13.88M13.88M
Diluted Shares Outstanding58.07M51.98M38.44M30.45M24.18M12.14M13.88M13.88M
EBITDA-221.51M-166.90M-106.78M-72.59M-49.31M-28.24M-9.00M-5.95M
EBITDA Margin-5,519.81%-3,523.31%-9,905.38%-102,233.80%-4,133.19%-1,163.06%-440.05%-1,010.53%
EBIT-214.53M-159.60M-107.64M-73.81M-50.42M-25.52M-9.19M-6.00M
EBIT Margin-5,345.85%-3,369.24%-9,985.25%-103,960.56%-4,226.49%-1,051.07%-449.34%-1,018.34%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙